The overall survival of ovarian cancer patients was closely associated with FIGO stage (p < 0.0001), lymph node metastasis (p < 0.0001) and p53 status (p = 0.0042) (Figure 10a-c). This evidence concerns the gene TP53 and ovarian cancer.